EU Grants iHIVARNA to Test an Innovative HIV Vaccine

EU Grants iHIVARNA to Test an Innovative HIV Vaccine

The iHIVARNA strategy proposes using an mRNA-based therapeutic vaccine encoding HIV antigens as a novel and promising approach in HIV immunotherapy. The four-year 6M€ European project iHIVARNA, funded by the European Commission, aims to successfully immunize...